119 related articles for article (PubMed ID: 7289887)
21. [The effects of progestin on the bone metabolism in postmenopausal women].
Ren Y; Zhu G
Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):135-7. PubMed ID: 7796643
[TBL] [Abstract][Full Text] [Related]
22. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
[TBL] [Abstract][Full Text] [Related]
23. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Marslew U; Overgaard K; Riis BJ; Christiansen C
Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
[TBL] [Abstract][Full Text] [Related]
24. Potential applications of high-dose megestrol acetate in breast cancer.
Abrams JS; Gutheil J; Aisner J
Oncology; 1992; 49 Suppl 2():12-7. PubMed ID: 1461620
[TBL] [Abstract][Full Text] [Related]
25. A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
Willemse PH; van der Ploeg E; Sleijfer DT; Tjabbes T; van Veelen H
Eur J Cancer; 1990 Mar; 26(3):337-43. PubMed ID: 2141491
[TBL] [Abstract][Full Text] [Related]
26. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
Need AG; Morris HA; Horowitz M; Nordin BE
Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
[TBL] [Abstract][Full Text] [Related]
27. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Bain SD; Jensen E; Celino DL; Bailey MC; Lantry MM; Edwards MW
J Bone Miner Res; 1993 Feb; 8(2):219-30. PubMed ID: 8442440
[TBL] [Abstract][Full Text] [Related]
28. Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.
Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
Clin Endocrinol (Oxf); 1993 Dec; 39(6):649-55. PubMed ID: 8287582
[TBL] [Abstract][Full Text] [Related]
29. High-dose progestin therapy for metastatic breast cancer.
Muss HB; Cruz JM
Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
[TBL] [Abstract][Full Text] [Related]
30. Megestrol acetate for the palliation of advanced ovarian carcinoma.
Geisler HE
Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
[TBL] [Abstract][Full Text] [Related]
31. Fasting urinary calcium/creatinine and hydroxyproline/creatinine values in young women with amenorrhoea and in matched eumenorrhoeic controls.
Goulding A; Rae BG; Bland R
N Z Med J; 1989 Dec; 102(881):629-30. PubMed ID: 2608225
[TBL] [Abstract][Full Text] [Related]
32. Plasma cortisol concentrations in women with menopausal flushes.
Tulandi T; Murphy BE; Lal S
Maturitas; 1985 Nov; 7(4):367-72. PubMed ID: 4079829
[TBL] [Abstract][Full Text] [Related]
33. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
[TBL] [Abstract][Full Text] [Related]
34. [Blood levels of megestrol acetate following injection of the microencapsulated compound megestrol acetate and its effect on pituitary-ovarian function].
Xu LZ; Han ZY; Yue YC; Yang SZ
Hua Xi Yi Ke Da Xue Xue Bao; 1988 Mar; 19(1):97-101. PubMed ID: 3391610
[No Abstract] [Full Text] [Related]
35. Effect of etidronate disodium on bone turnover following surgical menopause.
Smith ML; Fogelman I; Hart DM; Scott E; Bevan J; Leggate I
Calcif Tissue Int; 1989 Feb; 44(2):74-9. PubMed ID: 2492893
[TBL] [Abstract][Full Text] [Related]
36. Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.
Hodgkinson A; Thompson T
J Clin Pathol; 1982 Aug; 35(8):807-11. PubMed ID: 7107952
[TBL] [Abstract][Full Text] [Related]
37. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings.
Lundgren S; Lønning PE; Utaaker E; Aakvaag A; Kvinnsland S
J Steroid Biochem; 1990 Jun; 36(1-2):99-104. PubMed ID: 2362454
[TBL] [Abstract][Full Text] [Related]
38. Intra-individual variation in fasting urinary calcium- and hydroxyproline-creatinine ratios measured in metabolic bone clinic patients as both outpatients and inpatients.
Vasikaran SD; McCloskey EV; Kahn S; Kanis JA
Ann Clin Biochem; 1994 May; 31 ( Pt 3)():272-6. PubMed ID: 8067669
[TBL] [Abstract][Full Text] [Related]
39. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
Gal D; Edman CD; Vellios F; Forney JP
Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
[TBL] [Abstract][Full Text] [Related]
40. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women.
Ylöstalo P; Kauppila A; Kivinen S; Tuimala R; Vihko R
Obstet Gynecol; 1983 Dec; 62(6):682-6. PubMed ID: 6355937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
